AUAUniversity
361 episodes - English - Latest episode: 3 days ago - ★★★★★ - 32 ratingsThe AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma
October 06, 2021 05:30 - 88.6 MBRenal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment CME Available: https://auau.auanet.org/node/33917 At the conclusion of this course, participants will be able to: 1. Manage bleeding complications of robotic partial nephrectomy 2. Describe the algorithm of Immunotherapy treatment of advanced Renal Cell Carcinoma 3. Minimize positive margin rates of robotic partial nephrectomy ACKNOWLEDGEMENTS Independent educational grant su...
Management Of Non Muscle Invasive Bladder Cancer: Practical Solutions For Common Problems
September 29, 2021 05:29 - 86.5 MBCME Available: https://auau.auanet.org/node/33910 At the conclusion of this course, participants will be able to: 1. Implement current practice guidelines into the office setting. 2. Identify the best intravesical agent and duration of therapy for low, intermediate, and high risk settings and what to do during a BCG shortage. 3. Identify methods to treat significant toxicities from various intravesical therapies. 4. Define high risk scenarios that necessitate cystectomy and options for BCG-u...
Understanding Intrarenal Pressure
September 24, 2021 13:31 - 30 minutes - 27.6 MBThis podcast was funded by and developed in collaboration with Boston Scientific
Live from AUA2021: Highlights in Overactive Bladder (2021)
September 17, 2021 05:30 - 58 minutes - 53.7 MBCME Available: https://auau.auanet.org/node/33094 Acknowledgements This educational activity is supported by an independent educational grant from: Urovant
Live from AUA2021: Highlights in Advanced Prostate Cancer (2021)
September 15, 2021 05:30 - 1 hour - 55.7 MBCME Available: https://auau.auanet.org/node/33093 At the conclusion of the activity, participants will be able to: 1. Describe recent developments in the medical management of advanced prostate cancer. 2. Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC. 3. Discuss clinical investigations in the treatment of advanced prostate cancer. 4. Analyze the risks and benefits of treatment for advanced prostate cancer. 5. Identify the criteria for g...
NMIBC Guidelines
September 03, 2021 21:57 - 32 minutes - 29.6 MBNMIBC Guidelines by American Urological Association
Improving Racial Disparities in Treatment Outcomes Podcast
August 27, 2021 16:01 - 37 minutes - 34.2 MBSupport provided by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals Inc., Genentech, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Merck and Pfizer, Inc. CME Available: auau.auanet.org/node/31819 At the conclusion of this educational series, participants will be able to: 1. Discuss the impact of SDM on patients and on patient-clinician communication. 2. Identify at least one implementation strategy for using SDM in clinical practice....
Urolithiasis: Metabolic Evaluation and Medical Management
August 18, 2021 19:37 - 1 hour - 90.9 MBUrolithiasis: Metabolic Evaluation and Medical Management by American Urological Association
Optimizing Pre-Operative Care for Patients Undergoing Urologic Surgery
August 13, 2021 05:30 - 33 minutes - 30.2 MBOptimizing Pre-Operative Care for Patients Undergoing Urologic Surgery by American Urological Association
Reducing Opioid Exposure in the Perioperative Setting
July 28, 2021 05:30 - 33 minutes - 30.4 MBReducing Opioid Exposure in the Perioperative Setting by American Urological Association
An Overview of PARPi & Adverse Event Management
July 21, 2021 05:30 - 18 minutes - 17.2 MBThis podcast was funded by and developed in collaboration with AstraZeneca. Learning Objectives: At the conclusion of this activity, participants will be able to: 1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit from PARP Inhibitor‐based therapy. 2. Evaluate available clinical safety and efficacy data for PARP Inhibitors. 3. Describe indications and contraindications for PARP Inhibitors in patients with advanced prostate cancer. 4. Identify how to manage ...
Genomic Testing in Prostate Cancer
July 14, 2021 18:58 - 25 minutes - 23.1 MBThis podcast was funded by and developed in collaboration with AstraZeneca. Learning Objectives: At the conclusion of this activity, participants will be able to: 1. Identify the role of genomic testing in men with different stages of prostate cancer. 2. Recognize the need for collaboration with genetic counselors for optimal genetic evaluation tailored to an individual prostate cancer patient. 3. Explain the criteria for genomic testing of prostate cancer patients across the disease spectr...
Insight into Race, SDM and the Impact on Access to Quality Care Podcast
July 07, 2021 05:30 - 39 minutes - 35.8 MBSupport provided by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals Inc., Genentech, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Merck and Pfizer, Inc. CME Available: https://auau.auanet.org/node/31815 At the conclusion of this educational series, participants will be able to: 1. Discuss the impact of SDM on patients and on patient-clinician communication. 2. Identify at least one implementation strategy for using SDM in clinical p...
Surgical Management Of BPH
July 05, 2021 05:30 - 49 minutes - 45.5 MBThis educational series is supported by independent educational grants from Olympus Corporation of the Americas and Teleflex. CME Available: https://auau.auanet.org/node/32295 At the conclusion of this activity, participants will be able to: 1. Describe the role of the AUA Clinical Guidelines for the Surgical Management BPH. 2. Discuss the evidence base for current technologies, including pivotal studies, and be able to define the role and clinical expectation for each of them. 3. Interpre...
Genetic Testing In Bladder Cancer
June 30, 2021 05:30 - 28.7 MBThis podcast was funded by Janssen Oncology.
Genetic Testing in Bladder Cancer
June 30, 2021 05:30 - 31 minutes - 28.7 MBDesigned to encourage high quality, evidence-based testing and care of patients with bladder cancer, this podcast episode focuses on Genetic Testing for Bladder Cancer. Listen today to discover the differences between molecular markers and genetic testing, how genetic testing for bladder cancer is performed and current considerations of genetic findings. Co-Host: Neal Shore, MD, FACS Acknowledgement: This podcast was funded by Janssen Oncology. For more information: https://auau.auanet.or...
AUA2021 Kick Off Weekend: Contemporary Pharmacotherapy for OAB 2021
June 23, 2021 05:30 - 2 hours - 112 MBContemporary Pharmacotherapy for OAB 2021: Monotherapy and Combined Pharmacotherapy to Optimize Treatment (2021) CME Available: https://auau.auanet.org/node/31460 ACKNOWLEDGEMENTS Support provided by independent educational grants from AbbVie, Astellas, Medtronic, Urovant Sciences, Inc. At the conclusion of the activity, participants will be able to: 1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB). 2. Review the principles ...
AUA2021 Kick Off Weekend: Chemotherapy and Immunotherapy for the Urologist and APP
June 16, 2021 05:30 - 1 hour - 100 MBChemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider (2021) CME Available: https://auau.auanet.org/node/31450 ACKNOWLEDGEMENTS Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. At the conclusion of the activity, participants will be able to: 1. Explain the mechanism of checkpoint inhibitors. 2. D...
AUA2021 Kick Off Weekend: Trimodality Therapy for Management of Muscle Invasive Bladder Cancer
June 09, 2021 05:30 - 1 hour - 93.3 MBTrimodality Therapy for Management of Muscle Invasive Bladder Cancer (2021) CME Available: https://auau.auanet.org/node/31470 ACKNOWLEDGEMENTS Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck. At the conclusion of the activity, participants will be able to: 1. Demonstrate an understanding of prospective randomized trials and large institutional experiences in tri-modality therapy for muscularis propria invasive bladder cancer. 2. Identify ...
AUA2021 Kick Off Weekend: Diagnosis & Management of Localized & Advanced Kidney Cancer
June 02, 2021 05:30 - 1 hour - 99.6 MBDiagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer (2021) CME Available: https://auau.auanet.org/node/31465 ACKNOWLEDGEMENTS Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck. At the conclusion of the activity, participants will be able to: 1. Differentiate among the subtypes of kidney cancer, with emphasis on clinical management decisions and outline ways in which knowledge of kidney cancer subtypes can alte...
AUA2021 Kick Off Weekend: Incorporating Genomic Testing For Prostate Cancer into Your Practice
May 26, 2021 05:30 - 1 hour - 101 MBIncorporating Genomic Testing For Prostate Cancer into Your Practice (2021) CME Available: https://auau.auanet.org/node/31455 ACKNOWLEDGEMENTS Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. At the conclusion of the activity, participants will be able to: 1. Describe the seminal validation studies for prostate cancer gen...
Diversity In Urology: Initiatives And Opportunities
May 19, 2021 05:00 - 1 hour - 71.9 MBThis podcast webinar will introduce attendees to current diversity initiatives within urology. Panelists representing these programs will discuss the benefits of promoting diversity in urology, how their initiatives began, available resources and what urology residency programs and medical schools can do to promote diversity.
How to Manage a 65 Year Old Man with Bothersome LUTS and Underactive Bladder
May 12, 2021 05:30 - 30 minutes - 28.1 MBHow to Manage a 65 Year Old Man with Bothersome LUTS and Underactive Bladder by American Urological Association
PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The Community
May 05, 2021 05:30 - 52 minutes - 47.9 MBThis educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31224 Course Description: PARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentatio...
Multidisciplinary Discussion On Fertility, Hypogonadism & Sexual Function For Testis Cancer Patients
April 28, 2021 05:30 - 25 minutes - 23.6 MBMultidisciplinary Discussion On Fertility, Hypogonadism & Sexual Function For Testis Cancer Patients by American Urological Association
PARP Inhibitors: Assessing the Clinical Trial Landscape
April 21, 2021 05:30 - 54 minutes - 50.2 MBThis educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31223 Course Description: PARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentatio...
Controversies In Urology - Robotic Kidney Transplantation
April 14, 2021 05:30 - 34 minutes - 31.9 MBControversies In Urology - Robotic Kidney Transplantation by American Urological Association
Panel Discussion - Infection And Urologic Implants
April 12, 2021 16:35 - 22 minutes - 20.3 MBPanel Discussion - Infection And Urologic Implants by American Urological Association
PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
March 31, 2021 05:30 - 51 minutes - 47.5 MBThis educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest...
Metastatic Hormone Sensitive Prostate Cancer - Expert Guidance For Urologists
March 26, 2021 19:13 - 53 minutes - 49.2 MBThis educational series is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Pfizer, Inc. CME Available: https://auau.auanet.org/node/30861 In 2020, the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline was released and will provide critical guidance as the management of advanced prostate cancer patients continues to expand. To increase urologists understanding of how to translate the latest scientific adv...
Impacts of COVID-19 on Urology Training and Education
March 17, 2021 05:30 - 35 minutes - 32.8 MBImpacts of COVID-19 on Urology Training and Education by American Urological Association
Crossfire In Urology - Robotic Reconstruction
March 10, 2021 06:30 - 31 minutes - 28.4 MBCrossfire In Urology - Robotic Reconstruction by American Urological Association
Adjuvant Treatment In Bladder Cancer
March 03, 2021 06:30 - 38 minutes - 35.2 MBAt the conclusion of this activity, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of advanced bladder cancer and analyze the risks and benefits of the new and emerging treatment options. 2.Describe the mechanism of action and associated side effects of the new adjuvant therapy. 3. Differentiate the roles between the urologist and medical oncologist in the care of patients with bladder cancer. 4. Discuss the opportunities for the coordina...
AUA Guidelines Case - Based Panel Stress Urinary Incontinence
February 23, 2021 00:00 - 30 minutes - 27.6 MBAUA Guidelines Case - Based Panel Stress Urinary Incontinence by American Urological Association
Panel Discussion - Peyronie's Disease Management
February 19, 2021 21:47 - 30 minutes - 27.8 MBPanel Discussion - Peyronie's Disease Management by American Urological Association
Panel Discussion- Peyronie's Disease Management
February 19, 2021 21:47 - 27.8 MBPanel Discussion- Peyronie's Disease Management by AUAUniversity
Pain Management In Urologic Surgery
February 11, 2021 16:53 - 30 minutes - 27.9 MBPain Management In Urologic Surgery by American Urological Association
Bulbar Urethral Strictures 101 - A Review Of The Guidelines And Basic Management Options
February 03, 2021 18:31 - 31 minutes - 29.2 MBBulbar Urethral Strictures 101 - A Review Of The Guidelines And Basic Management Options by American Urological Association
Update Series - Dusting Vs Extraction Strategies During Ureteroscopy
January 26, 2021 00:00 - 24 minutes - 22.5 MBLearning Objective: At the conclusion of this continuing medical education activity, the participant will be able to select different strategies for ureteroscopic renal stone surgery, determine how laser parameter selection can improve lithotripsy efficiency and identify the important safety considerations to optimize patient outcomes.
GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For RCC
December 31, 2020 07:00 - 29 minutes - 27.2 MBAt the conclusion of this activity, participants will be able to: 1. Explain the sequencing of novel therapies and be able to identify patient progression of disease. 2. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological agents for the treatment of kidney cancer. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, L...
GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer
December 23, 2020 06:00 - 41 minutes - 37.7 MBAt the conclusion of this activity, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. 2. Explain best practices in MIBC and NMIBC patient selection for various treatment options. 3. Facilitate discussions with patients and caregivers regarding their treatment options. This educational series is supported by independent educational grants from: • Astellas • AstraZeneca • Bristol Myers Squibb • Jans...
Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy
December 20, 2020 00:00 - 27 minutes - 25 MBCase-Based Discussion: Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy and End-of-Life Care Podcast (2020) Presented by Leonard Gomella, MD and Joshua Lang, MD This educational activity is supported by independent educational grants from: AbbVie Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc. CME Available: https://auau.auanet.org/node/30124
Case-Based Discussion: Early M1 CRPC Management and Advanced M1 CRPC
December 18, 2020 00:00 - 34 minutes - 31.3 MBPresented by Kelly Stratton, MD and Alicia Morgans, MD This educational activity is supported by independent educational grants from: AbbVie Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc. CME Available: https://auau.auanet.org/node/30123
AUA SUO (2020) - Case - Based Discussion BCR And MHSPC And M0 CRPC
December 17, 2020 22:08 - 41.8 MBAUA SUO (2020) - Case - Based Discussion BCR And MHSPC And M0 CRPC by AUAUniversity
Case-Based Discussion: BCR and mHSPC & M0 CRPC
December 15, 2020 00:00 - 45 minutes - 41.9 MBCase-Based Discussion: BCR and mHSPC and M0 CRPC Presented by Stephen Boorjian, MD and Michael Cookson, MD This educational activity is supported by independent educational grants from: AbbVie Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc. CME Available: https://auau.auanet.org/node/30122
GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer
December 09, 2020 00:00 - 28 minutes - 26.3 MBAt the conclusion of this activity, participants will be able to: 1. Identify the role of genetic testing in men with advanced, metastatic and CRPC. 2. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 3. Describe results of genetic testing and relay this information to patients in order to facilitate shared-decision making based on the test results. 4. Explain the importance of testing for germline mutations and ...
GU Podcast (2020): Addressing Disparities in Prostate Cancer Care
December 02, 2020 06:00 - 32 minutes - 30.2 MBAt the conclusion of this activity, participants will be able to: 1. Examine racial and geographic disparities in in prostate cancer and prostate cancer care. 2. Identify important causes for disparities as well as possible remedies to address these causes. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, ...
GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma
November 25, 2020 06:00 - 38 minutes - 35.6 MBAt the conclusion of this activity, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and benefits of treatment. 2. Facilitate discussions with patients and caregivers regarding of urothelial carcinoma treatment options. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer...
GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Podcast: Part 2
November 18, 2020 18:53 - 21.2 MBAt the conclusion of this activity, participants will be able to: 1. Review the evidence and outcomes on the treatment of M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced, Metastatic and CRPC guidelines. 2. Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urological practice This educational series is supported by independent educational grants from: • Astellas • AstraZeneca • Bristol Myers Squibb • ...
GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline: Part 2
November 18, 2020 18:53 - 23 minutes - 21.2 MBAt the conclusion of this activity, participants will be able to: 1. Review the evidence and outcomes on the treatment of M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced, Metastatic and CRPC guidelines. 2. Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urological practice This educational series is supported by independent educational grants from: • Astellas • AstraZeneca • Bristol Myers Squibb • ...